The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma

In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging dia...

Full description

Saved in:
Bibliographic Details
Published in:Korean journal of radiology 2021, 22(1), , pp.23-40
Main Authors: Rhee, Hyungjin, Park, Mi Suk
Format: Article
Language:English
Subjects:
Adenocarcinoma - diagnostic imaging
Adenocarcinoma - pathology
Adenocarcinoma - therapy
Asymptomatic
Bile ducts
Cancer therapies
Chemotherapy
Endoscopy
Gastrointestinal Imaging
Humans
Lymphatic system
Magnetic Resonance Imaging
Metastasis
Neoadjuvant Therapy
Neoplasm Staging
Pancreatic cancer
Pancreatic Neoplasms - diagnostic imaging
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - therapy
Positron-Emission Tomography
Prognosis
Radiation therapy
Surveillance
Tomography
Tomography, X-Ray Computed
Tumors
Ultrasonic imaging
Ultrasonography
방사선과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.
ISSN:1229-6929
2005-8330
DOI:10.3348/kjr.2019.0862